Miyazaki, T., Shirakami, Y., Kubota, M., Ideta, T., Kochi, T., Sakai, H., . . . Shimizu, M. (2016). Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice. Oncotarget.

Miyazaki, Tsuneyuki, Yohei Shirakami, Masaya Kubota, Takayasu Ideta, Takahiro Kochi, Hiroyasu Sakai, Takuji Tanaka, Hisataka Moriwaki, and Masahito Shimizu. "Sodium Alginate Prevents Progression of Non-alcoholic Steatohepatitis and Liver Carcinogenesis in Obese and Diabetic Mice." Oncotarget 2016.

Miyazaki, Tsuneyuki, et al. "Sodium Alginate Prevents Progression of Non-alcoholic Steatohepatitis and Liver Carcinogenesis in Obese and Diabetic Mice." Oncotarget 2016.